Domenico Grosso
Overview
Explore the profile of Domenico Grosso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borrelli E, Barresi C, Ricardi F, Berni A, Grosso D, Viggiano P, et al.
Invest Ophthalmol Vis Sci
. 2024 Mar;
65(3):18.
PMID: 38470327
Purpose: To explore the occurrence of macular atrophy (MA) in eyes with age-related macular degeneration (AMD)-associated Type 3 macular neovascularization (MNV) treated with anti-vascular endothelial growth factor (anti-VEGF) therapy. Importantly,...
2.
Borrelli E, Oakley J, Iaccarino G, Russakoff D, Battista M, Grosso D, et al.
Eye (Lond)
. 2023 Sep;
38(3):537-544.
PMID: 37670143
Purpose: To validate a deep learning algorithm for automated intraretinal fluid (IRF), subretinal fluid (SRF) and neovascular pigment epithelium detachment (nPED) segmentations in neovascular age-related macular degeneration (nAMD). Methods: In...
3.
Borrelli E, Barresi C, Feo A, Lari G, Grosso D, Querques L, et al.
Sci Rep
. 2023 Feb;
13(1):3224.
PMID: 36828954
The aim of this study was to assess the relationship of clinical characteristics to the rate of retinal thinning in eyes with diabetic macular edema (DME) treated with anti-vascular endothelial...
4.
Borrelli E, Vigano C, Battista M, Sacconi R, Senni C, Querques L, et al.
Graefes Arch Clin Exp Ophthalmol
. 2022 Nov;
261(5):1267-1273.
PMID: 36441229
Purpose: To assess the diagnostic accuracy of individual and combined imaging modalities compared with multimodal imaging for the detection of choroidal neovascularization (CNV) in central serous chorioretinopathy (CSC). Methods: We...
5.
Borrelli E, Battista M, Barresi C, Grosso D, Gabela M, Quarta A, et al.
Retina
. 2022 Jun;
42(7):1238-1247.
PMID: 35723918
Purpose: To quantitatively evaluate the inner and outer choroidal changes in the fellow eyes of patients with unilateral central serous chorioretinopathy (CSC). Methods: We analyzed data from patients with a...
6.
Sacconi R, Forte P, Tombolini B, Grosso D, Fantaguzzi F, Pina A, et al.
Ophthalmol Retina
. 2022 Mar;
6(7):586-594.
PMID: 35227948
Purpose: To identify baseline OCT predictors of the 3-year visual outcome for type 3 (T3) macular neovascularization (MNV) secondary to age-related macular degeneration (AMD) treated by anti-vascular endothelial growth factor...
7.
Battista M, Cascavilla M, Grosso D, Borrelli E, Frontino G, Amore G, et al.
Sci Rep
. 2022 Feb;
12(1):2103.
PMID: 35136185
To evaluate differences in macular and optic disc circulation in patients affected by Wolfram Syndrome (WS) employing optical coherence tomography-angiography (OCTA) imaging. In this retrospective study, 18 eyes from 10...
8.
Borrelli E, Grosso D, Parravano M, Costanzo E, Brambati M, Vigano C, et al.
Sci Rep
. 2021 Oct;
11(1):19793.
PMID: 34611239
The aim of this study was to measure macular perfusion in patients with type 1 diabetes and no signs of diabetic retinopathy (DR) using volume rendered three-dimensional (3D) optical coherence...
9.
Sacconi R, Battista M, Borrelli E, Senni C, Tombolini B, Grosso D, et al.
Retina
. 2021 Sep;
42(2):381-387.
PMID: 34561405
Purpose: To investigate the correlation between choroidal vascularity index and the enlargement of geographic atrophy (GA) lesion secondary to age-related macular degeneration during the 2-year follow-up. Methods: In this longitudinal...
10.
Barresi C, Borrelli E, Fantaguzzi F, Grosso D, Sacconi R, Bandello F, et al.
Ophthalmologica
. 2021 Sep;
244(6):512-522.
PMID: 34517374
Background: Neovascular age-related macular degeneration (AMD) represents a leading cause of vision loss in older subjects. The introduction of anti-vascular endothelial growth factor therapy has enormously improved the visual prognosis...